# Prelude Therapeutics Inc: Form SCHEDULE 13D/A, filed Jun 13, 2025

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 17:21 ET
- Period: not reported
- Accession: 0001104659-25-059474
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000110465925059474/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000110465925059474/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000110465925059474/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-059474. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.